Skip to main content

Table 3 Laboratory findings in treated and untreated subjects of the elderly group

From: Hyperlipidemias in elderly patients: results from the Berlin Aging Study II (BASEII), a cross-sectional study

Study Group

Not treated with any lipid-lowering medication

Treated with any lipid-lowering medication

P

Total Number (n)/Percentage (%)

1357 (83.2%)

273 (16.8%)

 

Male

46.6%

58.4 %

<0.01

Current smoker

9.0%

10.8%

0.338

Consultation of a general practitioner during the last 3 months

58.3%

70.5%

<0.01

Arterial Hypertension (systolic BP >=140 mmHg and/or diastolic BP >=90 mmHg)

70.5%

83.2%

<0.01

Diabetes mellitus

9.1%

22.9%

<0.01

Chronic kidney disease (GFR <= 60mL/min/1,73m2)

6.7%

12.8%

<0.01

Coronary heart disease or equivalent

4.2%

24.0%

<0.01

Laboratory findings

Total cholesterol, median (IQR), mmol/L

5.7 (5.0 – 6.3)

4.8 (4.2 – 5.4)

<0.01

LDL-Cholesterol, median (IQR), mmol/L

3.5 (2.9 – 4.1)

2.6 (2.1 – 3.2)

<0.01

HDL-Cholesterol, median (IQR), all, mmol/L

1.6 (1.3 – 1.9)

1.5 (1.2 – 1.8)

<0.01

HDL-Cholesterol, median (IQR), by sex, mmol/L

female 1.8 (1.5–2.1)

male1.4 (1.1-1.7)

female 1.7 (1.4-2.0)

male 1.4 (1.1-1.6)

0.04/ <0.16

Lipoprotein(a), median (IQR), mg/dL

11.0 (4.2 – 31.9)

11.0 (5.0 – 41.5)

0.163

Triglycerides, median (IQR), mmol/L

1.1 (0.8 – 1.5)

1.2 (0.9 – 1.7)

<0.01

LDL-C at target, ESC-Guidelines

5.6%

16.5%

<0.01

  1. Abbreviations: BP: blood pressure, ESC: European Society of Cardiology, GFR: glomerular filtration rate, HDL: high density lipoprotein, IQR: interquartile range, LDL: low density lipoprotein, Lp(a): Lipoprotein(a), SD: standard deviation